Xiao Xu and Qi Yanbin ᱨᱮᱱᱟᱜ Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ

Xiao Xu and Qi Yanbin ᱨᱮᱱᱟᱜ Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ ᱫᱚ ᱪᱤᱠᱤᱛᱥᱟ ᱩᱛᱯᱟᱫ ᱯᱨᱚᱛᱤᱡᱚᱜᱤᱛᱟ ᱵᱷᱟᱜ ᱨᱮ 2023 A' Design Award ᱨᱩᱯᱟ ᱯᱩᱨᱚᱥᱠᱟᱨ ᱨᱮᱱᱟᱜ ᱟᱹᱰᱤ ᱢᱟᱱ ᱟᱠᱟᱱ ᱡᱤᱛᱠᱟᱨ ᱠᱟᱱᱟ᱾

ᱨᱩᱯᱟᱪᱤᱠᱤᱛᱥᱟ ᱩᱛᱯᱟᱫ· 2023

Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ

Xiao Xu and Qi Yanbin ᱞᱮᱠᱟᱛᱮ

ᱜᱟᱦᱟᱠ: Nanjing Yinuoji Medical Technology Co., Ltd.

ᱪᱤᱠᱤᱛᱥᱟ ᱩᱛᱯᱟᱫ ᱵᱷᱟᱜ ᱨᱮ A' Design Award ᱨᱩᱯᱟ ᱯᱩᱨᱚᱥᱠᱟᱨ ᱡᱤᱛᱠᱟᱨ

146,412

ᱡᱟᱸᱪ ᱟᱠᱟᱱ ᱮᱣᱟᱨᱰ ᱡᱤᱛᱠᱟᱨ

#149906 ᱞᱟᱜᱤᱫ ᱮᱣᱟᱨᱰ ᱦᱟᱞᱚᱛ ᱡᱟᱸᱪ

A' Design Award ᱨᱮ ᱧᱮᱞ ᱢᱮ ᱯᱨᱮᱥ ᱨᱤᱞᱤᱡ ᱯᱩᱨᱥᱠᱟᱨ ᱵᱮᱡ

ᱨᱚᱝ

ᱰᱤᱡᱟᱭᱤᱱ

Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ ᱵᱟᱵᱚᱛ ᱛᱮ

ᱤᱱᱚᱜᱤ ᱟᱨ1 ᱫᱚ ᱨᱟᱬ ᱵᱮᱵᱷᱟᱨ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫᱴᱟᱹᱝ ᱦᱩᱰᱤᱧ ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ ᱠᱟᱱᱟ᱾ ᱱᱚᱶᱟ ᱡᱤᱱᱤᱥ ᱫᱚ ᱢᱤᱫ ᱴᱤᱯᱤᱡ ᱨᱮ 6 ᱞᱤᱴᱚᱨ ᱦᱟᱹᱵᱤᱡ ᱯᱚᱞᱥ ᱵᱚᱦᱮᱞᱟᱜ ᱚᱠᱥᱤᱡᱮᱱ ᱮᱢᱮᱫᱟᱭ᱾ ᱤᱱᱚᱜᱤ ᱟᱨ1 ᱫᱚ ᱢᱚᱞᱤᱠᱩᱞᱟᱨ ᱪᱷᱟᱹᱱᱤ ᱛᱮ ᱦᱚᱭ ᱠᱷᱚᱱ ᱚᱠᱥᱤᱡᱮᱱ ᱮ ᱵᱮᱜᱚᱨ ᱟᱭ, ᱚᱱᱟᱛᱮ ᱡᱟᱦᱟᱱ ᱮᱴᱟᱜ ᱡᱤᱱᱤᱥ ᱵᱟᱝ ᱞᱟᱹᱠᱛᱤᱭᱟ, ᱟᱨ 90 ᱯᱨᱚᱛᱤᱥᱚᱛ ᱠᱷᱚᱱ ᱡᱟᱹᱥᱛᱤ ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱥᱚᱱ ᱮ ᱥᱮᱴᱮᱨᱟ᱾ ᱟᱡ ᱛᱮ ᱛᱮᱭᱟᱨ ᱟᱠᱟᱱ ᱠᱚᱱᱴᱨᱚᱞ ᱥᱤᱥᱴᱚᱢ ᱛᱮ 6000 ᱢᱤᱴᱚᱨ ᱦᱟᱹᱵᱤᱡ ᱩᱥᱩᱞ ᱡᱟᱭᱜᱟ ᱨᱮ ᱟᱨ ᱢᱟᱭᱱᱚᱥ 30 ᱰᱤᱜᱽᱨᱤ ᱥᱮᱞᱥᱤᱭᱚᱥ ᱦᱟᱹᱵᱤᱡ ᱨᱟᱵᱟᱝ ᱨᱮᱦᱚᱸ ᱠᱟᱹᱢᱤ ᱫᱚ ᱥᱚᱡᱷᱮ ᱛᱟᱦᱮᱸᱱᱟ᱾ ᱵᱮᱴᱨᱤ ᱥᱟᱶᱛᱮ ᱱᱚᱶᱟ ᱡᱤᱱᱤᱥ ᱨᱮᱱᱟᱜ ᱢᱟᱯ ᱫᱚ 17.7 ᱜᱩᱱᱟᱱ 7.7 ᱜᱩᱱᱟᱱ 19.4 ᱥᱮᱱᱴᱤᱢᱤᱴᱚᱨ ᱠᱟᱱᱟ ᱟᱨ ᱦᱟᱢᱟᱞ ᱫᱚ 1.8 ᱠᱤᱞᱚᱜᱽᱨᱟᱢ ᱠᱟᱱᱟ᱾ ᱢᱚᱞᱤᱠᱩᱞᱟᱨ ᱪᱷᱟᱹᱱᱤ ᱟᱨ ᱵᱮᱴᱨᱤ ᱫᱚ ᱢᱤᱫ ᱫᱷᱟᱣ ᱛᱮᱜᱮ ᱵᱚᱫᱚᱞ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ᱾

ᱢᱟᱱᱟᱱ

A' Design Award ᱨᱩᱯᱟ ᱯᱩᱨᱚᱥᱠᱟᱨ ᱵᱟᱵᱚᱛ ᱛᱮ

Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ ᱫᱚ A' Design Award ᱨᱩᱯᱟ ᱯᱩᱨᱚᱥᱠᱟᱨ ᱧᱟᱢ ᱟᱠᱟᱱᱟ, ᱱᱚᱶᱟ ᱫᱚ ᱥᱩᱱᱫᱚᱨ ᱟᱨ ᱵᱷᱟᱞᱟᱭ ᱰᱤᱡᱟᱭᱤᱱ ᱠᱚ ᱞᱟᱹᱜᱤᱫ ᱮᱢ ᱟᱠᱟᱱ ᱥᱚᱢᱟᱱ ᱠᱟᱱᱟ᱾ ᱱᱚᱶᱟ ᱠᱚ ᱫᱚ ᱰᱤᱡᱟᱭᱤᱱᱟᱨ ᱠᱚ ᱨᱮᱭᱟᱜ ᱵᱷᱟᱵᱱᱟ ᱟᱨ ᱵᱷᱟᱞᱟᱭ ᱠᱟᱢᱤ ᱡᱷᱟᱞᱠᱟᱣ ᱠᱚ᱾ Inogi R1 ᱚᱠᱥᱤᱡᱮᱱ ᱠᱚᱱᱥᱮᱱᱴᱨᱮᱴᱚᱨ ᱫᱚ ᱠᱚᱞᱟ, ᱣᱤᱜᱭᱟᱱ, ᱰᱤᱡᱟᱭᱤᱱ ᱟᱨ ᱴᱮᱠᱱᱚᱞᱚᱡᱤ ᱨᱮᱭᱟᱜ ᱥᱤᱢᱟ ᱵᱟᱲᱦᱟᱣ ᱟᱨ ᱫᱩᱱᱤᱭᱟ ᱵᱷᱟᱞᱟᱭ ᱞᱟᱹᱜᱤᱫ ᱜᱚᱲᱚ ᱮᱢ ᱠᱟᱱᱟ᱾

ᱰᱤᱡᱟᱭᱤᱱ ᱯᱤᱪᱷᱟ ᱨᱮ

ᱯᱨᱮᱥ ᱠᱤᱴ

ᱰᱤᱡᱟᱭᱤᱱᱟᱨ ᱧᱮᱞ ᱠᱷᱚᱱ ᱠᱨᱮᱰᱤᱴ, ᱴᱤᱢ ᱥᱫᱚᱥᱭ ᱟᱨ ᱴᱮᱠᱱᱤᱠᱮᱞ ᱵᱤᱵᱚᱨᱚᱬ ᱮᱢ ᱟᱠᱟᱱᱟ᱾

ᱟᱞᱜᱟ ᱜᱩᱱ ᱠᱚ: INOGI-R1 is the first medical grade miniaturized oxygen concentrator with a pulse flow rate of up to 6 L/min. By integrating all functions of those 20kg concentrators from other brands in a compact size, INOGI-R1 is wildly used clinically. The in-house developed “Micro Pressure Control Analysis Technique” adapts to high pressure and low temperature conditions, which supports stable use even at high altitudes (6000m) or in low temperatures (-30°C). This product has been favored among consumers due to impressive performance and affordability.
ᱢᱟᱯ ᱟᱨ ᱯᱮᱠᱮᱡᱤᱝ: With battery cell: 17.7*7.7*19.4cm, 1.8kg
Without battery cell: 17.7*7.7*16cm, 1.3kg
INOGI-R1 is 33% smaller and 23% lighter than similar products.
ᱴᱮᱜ ᱠᱚ: Oxygen generator, miniaturized oxygen generator, COPD, aerospace materials, in-house innovation, medical device, portable device
ᱛᱮᱭᱟᱨ ᱛᱮᱠᱱᱚᱞᱚᱡᱤ: Backed by the in-house developed control system and an aerospace material compressor, this instrument only uses air instead of any additive to separate oxygen and nitrogen in the air, and filters out all kinds of impurities through the molecular sieve. It allows an unlimited access to oxygen at a concentration above 90% only depending upon power consumption. It comes with an efficient ARM processor that supports precise detection and fast signal processing. The in-house developed intelligent MAAS system simplifies the operation process and enables physical abnormality early warning and health advice, including breathing sensitivity control, breathing rate in-depth monitoring, and big data health management system.
ᱰᱤᱡᱟᱭᱱ ᱪᱮᱞᱮᱧ: The release of INOGI-R1 provides a good solution for the common technical problems of China’s medical oxygen machine products, including poor stability over a long time, inefficient working of molecular sieve, high power consumption and short service life of compressor, enhances the independent innovation capacity of China’s medical oxygen generators. At present, this product has been granted 47 patents and property rights, which fills the void of subminiaturized high-altitude ultra-low temperature medical grade portable oxygen supply in China, breaking the monopoly of overseas products.
ᱜᱚᱵᱮᱥᱚᱱᱟ: According to a survey, there are about 100 million patients with Chronic Obstructive Pulmonary Disease (COPD) in China, with the rate of missed diagnosis up to 70%, and most patients are often unaware of their discomfort. In this context, efforts should be made to raise the awareness of COPD and turn the scale of poor treatment. Backed by robust features, INOGI-R1 is believed to relieve the discomfort and pain caused by cardiopulmonary dysfunction.
ᱯᱨᱮᱨᱚᱱᱟ: The oxygen flow rate of commercially available products is up to 5L/min, which is only suitable for patients with mild illnesses and far from attaining the desired medical effect. These deficiencies motivate us to tailor a miniaturized oxygen concentrator with a pulse flow rate of up to 6L/min for lung disease patients with inaccessible oxygen supply.
ᱯᱨᱚᱡᱮᱠᱴ ᱥᱚᱢᱚᱭ: The project commenced in Nanjing, Jiangsu in September 2018, R&D of the complete unit was done and the revolutionary product INOGI-R1 was released in April 2021, exhibited at the IF and Red Dot in April and September 2022 respectively, and also exhibited at the IDPA Exhibition in Tokyo in November 2022.
ᱠᱟᱹᱢᱤ ᱦᱚᱨ: In addition to the medical field, the use of INOGI-R1 can be further extended to health care, high altitude exercises, highland travel, protection in exercise, emergency rescue, ect., and it is mainly intended for the elderly, children, pregnant women, sub-healthy white-collar workers and students. In addition, INOGI-R1 works properly at the highest altitude of 6,000m and the lowest temperature of -30℃, which immensely broadens the range of applications and scenarios. In the course of everyday use, 100W super charger is enough to keep the unit working for long hours without battery, reducing the environmental impact of battery. This instrument is continuously powered with working hours up to 6 hours after 2-hour fast charge, which can be used even in long hours of traveling. The molecular sieve and the battery can be installed and replaced with one-click operation.
ᱴᱤᱢ ᱥᱮᱫᱟᱭ ᱠᱚ: Xu Xiao、Qi Yanbin